Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 197-210

  Correale, J ^a,b   Gilmore, W ^a   Li, S ^a   Walsh, J ^a   Bassani, M M ^b   Lund, Brett ^a   Arias, M ^a   Weiner, L P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Inst of Neurol Res 'Dr Raul C'   (Argentina)

Author keywords

Apoptosis; Autoimmunity; Glucocorticoids; Multiple Sclerosis; T cell clones

Indexed keywords

B7 ANTIGEN; COMPLEMENTARY DNA; GLUCOCORTICOID; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RECOMBINANT INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE;

ADULT; APOPTOSIS; AUTOANTIGENS; CLONE CELLS; CYCLINS; DEXAMETHASONE; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; IN VITRO; INTERLEUKIN-2; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MYELIN PROTEOLIPID PROTEIN; PROTEIN P53; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034703185     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00326-X     Document Type: Article

References (87)

1. Akbar A., Borthwick N., Salmon M., Gombert W., Bofill M., Shamsadeen N., Pilling D., Pett S., Grundy J., Janossy G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med. 178:1993;427-438.
2. Arsura M., Wu M., Sonenshein G. TGFβ1 inhibits NF-kB/rel activity inducing apopotosis of B cells: transcriptional activation of IkBα Immunity. 5:1996;31-40.
3. Auphan N., DiDonato J., Rosette C., Helmberg A., Karin M. Immunosuppression by Glucocorticoids: Inhibition of NF-kB activity through induction of Ikb synthesis. Science. 270:1995;286-290.
4. Batuman O., Ferrero A., Diaz A., Jimenez S. Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1991;1574-1580.
5. Bauerle P., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
6. Beutler B., Krochin N., Milsark I., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 232:1986;977-980.
7. Bissonnette R., Echeverri F., Mahboubi A., Green D. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554.
8. Bö L., Dawson T., Wesselingh S., Mork S., Choi S., Kong P., Hanley D., Trapp B. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
9. Boehme S., Lenardo M. TCR-mediated death of mature T lymphocytes occurs in the absence of p53. J. Immunol. 156:1996;4075-4078.
10. L. Immunity. 3:1995;87-98.
11. Bright J., Kerr L., Sriram S. TGF-beta inhibits IL-2 induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J. Immunol. 159:1997;175-183.
12. Broome H., Dergan C., Krajewski S., Reed J. Expression of Bcl-2, Bcl-x and Bax after T cell activation and IL-2 withdrawal. J. Immunol. 155:1995;2311-2317.
13. Cohen J., Duke R. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:1984;38-42.
14. Cohen J., Duke R., Fadok V., Sellins K. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:1992;267-293.
15. Collart M., Belin D., Vasalli J., Vassalli P. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J. Immunol. 139:1987;949-955.
16. Correale J., McMillan M., McCarthy K., Le T., Weiner L. Isolation and characterization of autoreactive proteolipid protein T cell clones from multiple sclerosis patients. Neurology. 45:1995;1370-1378.
17. Correale J., Gilmore W., McMillan M., Li S., McCarthy K., Le T., Weiner L.P. Patterns of cytokine secretion by autoreactive proteolipid protein T cell clones during the course of Multiple Sclerosis. J. Immunol. 154:1995;2959-2968.
18. Correale J., Gilmore W., Lopez J., McMillan M., Weiner L. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nature Med. 2:1996;1354-1360.
19. Correale J., McMillan M., Li S., McCarthy K., Le T., Weiner L.P. Antigen presentation by autoreactive proteolipid protein T cell clones from chronic progressive MS patients. Roles of co-stimulatory B7 molecules and IL-12. J. Neuroimmunol. 72:1997;27-43.
20. Critchfield J., Boehme S., Lenardo M. The regulation of antigen-induced mature T cell apoptosis. Gregory C. Apoptosis and the Immune Response. 1994;55-114 John Wiley & Sons, New York.
21. Datto M., Yu Y., Wang X. Functional analysis of the transforming growth factor β responsive elements in the WAF 1/Cip 1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
22. DiBattista J., Martel-Pelletier J., Antakly T., Tardif G., Cloutier J., Pelletier J. Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes. Role in the suppression of metalloprotease synthesis. J. Clin. Endocrinol. Metab. 76:1993;1128-1134.
23. El-Deiry W., Tokino T., Velculescu V., Levy D., Parsons R., Trent J., Lin D., Mercer W., Kinzler K., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
24. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
25. Golstein P., Ojcius D., Young D. Cell death mechanisms and the immune system. Immunol. Rev. 121:1991;29-65.
26. Goodkin D. Current disease modifying therapies in Multiple Sclerosis. Raine C.S., McFarland H.F., Tourtellote W.W. Multiple Sclerosis: Clinical and Pathogenic Basis. 1997;309-323 Chapman & Hall Medical, London.
27. Goya L., Maiyar A., Ge Y., Firestone G. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Mol. Endocrinol. 7:1993;1121-1132.
28. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature. 371:1994;257-260.
29. Hsieh S., Kidd G., Crawford T., Xu Z., Lin W., Trapp B., Cleveland D., Griffin J. Regional modulation of neurofilament organization by myelination in normal axons. J. Neurosci. 14:1994;6392-6401.
30. Hughes D., Dai A., Tiffee J., Li H., Mundy G., Boyce B. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2:1996;1132-1136.
31. Hunter S., Weinshenker B., Carter J., Noseworthy J. Rational Clinical Immunotherapy for Multiple Sclerosis. Mayo Clin. Proc. 72:1997;765-780.
32. Jonat C., Rahmsdorf H., Park K., Cato A., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
33. Kam J., Szeler S., Surs W., Sher E., Leung D. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151:1993;3460-3466.
34. Knudsen P., Dinarello C., Strom T. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 139:1987;4129-4134.
35. Krett N., Pillay S., Moalli P., Greipp P., Rosen S. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res. 55:1995;2727-2729.
36. Leung D., Martin R., Szefler S., Sher E., Ying S., Kay A., Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181:1995;33-40.
37. Leung D., Hamid Q., Vottero A., Szefler S., Surs W., Minshall E., Chrousos G., Klemm D. Association of glucocorticoid insensitivity with increased expression of glucocoticoid receptor β J. Exp. Med. 186:1997;1567-1574.
38. Levine A. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
39. Li C., Suardet L., Little J. Potential role of WAF 1/Cip 1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:1995;4971-4974.
40. Lomo J., Blomhoff H., Beiske K., Stokke T., Smedland E. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154:1995;1634-1643.
41. Lowe S., Schmitt E., Smith S., Osborne B., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
42. Lowe S., Ruley H., Jacks T., Housman D. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
43. Martin R., McFarland H., McFarlin D. Immunological aspects of demyelinanting diseases. Annu. Rev. Immnunol. 10:1992;153-187.
44. Martins T., Águas A. Involvement of c-myc in the resistance of non-obese diabetic mice to glucocorticoid-induced apoptosis. Immunology. 95:1998;377-382.
45. McDonald H., Lees R. Programmed death of autoreactive thymocytes. Nature. 343:1990;642-644.
46. Meyers L. Treatment of Multiple Sclerosis with ACTH and corticosteroids. Rudick R.A., Goodkin D.E. Treatment of Multiple Sclerosis: Trial design, results and future perspectives. 1992;135-156 Springer-Verlag, London.
47. Morgan D. Principles of CDK regulation. Nature. 374:1995;131-134.
48. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
49. Noel P., Boise L., Green J., Thompson C. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:1996;636-642.
50. Oberhammer F., Pavelka M., Sharma S., Tiefenbacher R., Purchio A., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl. Acad. Sci. USA. 89:1992;5408-5412.
51. Olaso R., Pairault C., Baulogne B., Durand P., Haser R. Transforming growth factor beta 1 and beta 2 reduce the number of gonocytes by increasing apoptosis. Endocrinology. 139:1998;733-740.
52. Palogianni F., Raptis A., Ahuja S., Najjar S., Boumpas D. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J. Clin. Invest. 91:1993;1481-1489.
53. Polyak K., Kato J., Solomon M., Sherr Ch., Massague J., Reberts J., Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
54. Polyak K., Xia Y., Zweier J., Kinzler K., Vongelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
55. Raine C. The immunology of the multiple sclerosis lesions. Ann. Neurol. 36:1994;S61-S72.
56. Ropke C., Gladstone P., Nielsen M., Borregaard N., Ledbetter J., Suejgaard H., Odum N. Apoptosis following interleukin-2 withdrawal from T cells: evidence for a regulatory role of CD18 (beta 2-integrin) molecules. Tiss. Antig. 48:1996;127-135.
57. Rosenberg G.A., Dencoff J.E., Correa N., Reiners M., Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology. 46:1996;1626-1632.
58. Rotello R., Lieberman R., Purchio A., Gerschenson L. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;3412-3415.
59. Saltis J. TGF-β: receptors and cell cycle arrest. Mol. Cell Endocrinol. 116:1996;227-232.
60. Sanchez I., Hassinger L., Paskevich P., Shine H., Nixon R. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J. Neurosci. 16:1996;5095-5105.
61. Scheinman R., Cogswell P., Lofquist A., Baldwin A. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
62. Schlaghecke R., Kornley E., Wollenhaupt J., Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 35:1992;740-744.
63. Schule R., Rangarajam P., Kliewer S., Ransone L., Bolado J., Yang N., Verma I., Evans R. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 62:1990;217-1226.
64. Seki M., Ushiyama Ch., Seta N., Abe K., Fukazawa T., Asakawa J., Takasaki Y., Hashimoto H. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;823-830.
65. Selmaj K., Raine C., Canella B., Brosman C. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
66. Sentman C., Shutter L., Hockenberry D., Kanagawa O., Korsmeyer S. bcl-2 inhibits multiple forms of apoptosis but not negative selection in the thymocytes. Cell. 129:1991;879-888.
67. Serrano M., Hannon G., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707.
68. Shahidi H., Vottero A., Stratakis C., Taymans S., Karl M., Longui C., Chrousos G., Daughaday W., Gregory S., Plate J. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. and Biophys. Res. Comm. 254:1999;559-565.
69. Sher E., Leung D., Surs W., Kam J., Zieg G., Kamada A., Szefler S. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. 93:1994;33-39.
70. Sherr C. Cancer cell cycles. Science. 274:1996;1672-1677.
71. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function or NF-kappa B. Annu. Rev. Cell Biol. 10:1994;405-455.
72. Strasser A., Harris A., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
73. Strasser-Wozak E., Hattmannstorfer R., Hala M., Hartmann B., Fiegl M., Geley S., Kofler R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 55:1995;348-353.
74. Tuosto L., Cundari E., Gilardi Montani M., Picolella E. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur. J. Immunol. 24:1994;1061-1065.
75. + T cells are resistant to glucocorticoid-induced apoptosis: Implications for the Th1/Th2 balance. J. Immunol. 161:1998;1239-1247.
76. Tamura A., Katsumata M., Greene M.I., Yui K. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice. Cell Immunol. 168:1996;220-228.
77. Trapp B., Peterson J., Ransohoff R., Rudick R., Mörk S., Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
78. Van Engeland M., Nieland L., Ramaekers F., Schutte B., Reuterlingsperger C. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 31:1998;1-9.
79. Vaux D., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
80. Von Knebel Doeberitz M., Koch S., Drzonek H., Zur Hausen H. Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells. Eur. J. Immunol. 20:1990;35-40.
81. Wagner D., Hagman J., Linsley P., Hodsdon W., Freed J., Newell K. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184:1996;1631-1638.
82. Waldman T., Kinzler K., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
83. Wyllie A. Glucocorticoid-induced thymocyte apopotosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-558.
84. Xiong Y., Zhang H., Beach D. d type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514.
85. Yang E., Korsmeyer J. Molecular thanatopsis: a discourse on the BCL 2 family and cell death. Blood. 88:1996;386-401.
86. Zang Y., Kozovska M., Hong J., Li S., Mann S., Killian J., Rivera V., Zhang J. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur. J. Immunol. 29:1999;1692-1700.
87. Zipp F., Martin R., Lichtenfels R., Roth W., Dichgans J., Krammer P.H., Weller M. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J. Immunol. 159:1997;2108-2115.